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Abstract: We examined whether CXCL12α improves insulin secretion by influencing the Ca2+ oscillation pattern and Ca2+ 
influx ([Ca2+]i), thereby enhancing the viability of pancreatic islet cells in oxidative stress. The islets of Langerhans were 
isolated from male OF1 mice and pretreated with 40 ng/mL of CXCL12α prior to exposure to 7.5 µM hydrogen peroxide, 
which served to induce oxidative stress. Incubation of islets with CXCL12α induced pancreatic β-cell proliferation and 
improved the ability of β-cells to withstand oxidative stress. Consecutive treatments of isolated islets with hydrogen peroxide 
caused a decline in β-cell functioning over time, while the CXCL12α pretreatment of islets exhibited a physiological response 
to high glucose that was comparable to control islets. The attenuated response of islets to a high D-glucose challenge was 
observed as a partial to complete abolishment of [Ca2+]i. Treatments with increasing concentrations of CXCL12α decreased 
the number of Ca2+ oscillations that lasted longer, thus pointing to an overall increase in [Ca2+]i, which was followed by 
increased insulin secretion. In addition, treatment of islets with CXCL12α enhanced the transcription rate for insulin and 
the CXCR4 gene, pointing to the importance of CXCL12/CXCR4 signaling in the regulation of Ca2+ intake and insulin 
secretion in pancreatic islet cells. We propose that a potential treatment with CXCL12α could help to remove preexisting 
glucotoxicity and associated temporary β-cell stunning that might be present at the time of diabetes diagnosis in vivo.
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IntRoduCtIon
Diabetes is characterized either by a near-absolute 
absence (type 1 diabetes; T1D) or depletion (type 2 
diabetes; T2D) of pancreatic β-cells that is responsi-
ble for the condition that is described by insufficient 
or impaired insulin secretion. Therefore, β-cell mass 
regulation and improved β-cell viability and function 
through the stimulation of insulin secretion represent 
a focal point for prospective diabetes management.
Insulin secretion from the pancreatic β-cells in-
duced primarily by glucose is mediated by the known 
mechanism that involves: raising the ratio of ATP/
ADP, closing the ATP-sensitive K+ (KATP) chan-
nels leading to plasma membrane depolarization, 
voltage-gated calcium (Cav) channels activation and 
increased Ca2+ influx ([Ca2+]i) [1]. Finally, increased 
[Ca2+]i triggers the exocytosis of insulin-containing 
granules. There is extensive literature that examines 
the relationship between β-cell electrical activity and 
intracellular Ca2+ concentration, both in the islets of 
Langerhans and in isolated islet cells [2-6]. Increased 
glucose concentration induces several types of cycli-
cal spike activity and Ca2+ oscillations with different 
periods in insulin-secreting cells [7]. The Ca2+ oscil-
lations are closely linked to multiple key aspects of 
β-cell functioning in physiological and pathological 
conditions. There are several Ca2+ oscillation types: 
“fast”, with a period from several seconds to one 
minute, “slow”, with a period ranging from one to 
several minutes and “mixed” (or compound) oscilla-
tions characterized by fast oscillations superimposed 
on slow oscillations [8]. Numerous hormones, small 
molecule agonists as well as toxins can change the 
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Ca2+ oscillatory behavior of β-cells thereby influencing 
[Ca2+]i and insulin secretion.
Results obtained from β-cell research recently high-
lighted the important role of CXC chemokine ligand12 
(CXCL12) in enhancing β-cell viability and prolifera-
tion. This positioned CXCL12 as a potentially impor-
tant molecule for the treatment of diabetes. CXCL12 
belongs to the CXC group of chemokines. It was first 
discovered as a pre-B cell growth-stimulating factor 
[9,10] that is also important for the proper formation 
of multiple organ systems. It has a significant role in 
tissue development, repair and regeneration [11-13]. 
CXCL12 is a ligand for two transmembrane receptors: 
CXCR4 and CXCR7 [14,15]. It was shown to stimulate 
β-cell survival by preventing apoptosis via activation 
of the prosurvival kinase Akt, which consequently up-
regulates the expression of antiapoptotic protein Bcl-
2 and phosphorylates the proapoptotic protein Bad 
[16]. Transgenic mice overexpressing CXCL12 in their 
β-cells are resistant to β-cell apoptosis and diabetes. 
Our laboratory revealed a CXCL12-mediated improve-
ment of β-cell viability, which is based on CXCL12 an-
tinecrotic action through the modulation of PARP-1 
activity [17]. Furthermore, CXCL12 is involved in the 
regulation of insulin secretion [18]. Since diabetes re-
sults from an insufficient number of β-cells or a lack 
of their functionality, the important role of CXCL12 in 
the process of increased β-cell viability and boosting of 
insulin secretion in the pancreas is of particular interest 
for the potential treatment of diabetes.
The present work sought to investigate if and by 
which mechanism CXCL12 signaling could confer 
insulinotropic effects under physiological and oxida-
tive stress conditions in the intact islets of Langerhans. 
We hypothesized that the delivery of CXCL12 to intact 
mouse Langerhans islets would improve viability and 
increase insulin secretion, influencing the Ca2+ oscil-
lation pattern, [Ca2+]i and overall concentration of the 
Ca2+ in the cytosol.
MAteRIAls And Methods
Animals
All protocols followed the regulations approved by the 
Animal Care Committee of the Universidad Miguel 
Hernández according to national and European poli-
cies about ethics in animal research. Swiss albino OF1 
mice (8-10 weeks old) were used.
Isolation of mouse pancreatic islets
Swiss albino OF1 male mice were killed by cervical 
dislocation and pancreatic islets were isolated by colla-
genase (Sigma, Madrid, Spain) digestion as previously 
described [19]. Briefly, islet isolation was performed in 
Hank’s balanced salt solution (HBSS; 115 mM NaCl, 
10 mM NaHCO3, 5 mM KCl, 1.2 mM NaH2PO4, 25 
mM HEPES, 1.1 mM MgCl2) containing 1% (wt/vol) 
bovine serum albumin (BSA; fraction V) (Sigma, Ma-
drid, Spain) and 5 mM glucose. The pancreas was 
cannulated by infusion of a 10-mL solution of 1.0 mg/
mL collagenase in supplemented HBSS into the com-
mon bile duct. The distended pancreas was excised, 
transferred to a flask tube and incubated at 37°C with 
1.0 mg/mL of collagenase in supplemented HBSS for 
20 min. The digestion was stopped by adding cold 
supplemented HBSS solution. Using a dissection mi-
croscope and an external light source, the islets were 
handpicked (handpicking was repeated three times). 
The islets were cultured in groups in RPMI 1640 with-
out phenol red at 37°C in a humidified atmosphere 
of 95% O2 and 5% CO2 for 48 h. The medium was 
supplemented with 10% fetal bovine serum (Thermo 
Scientific), 2 mM L-glutamine, 200 U/mL penicillin 
and 0.2 mg/mL streptomycin. To obtain single islet 
cell suspensions, the isolated islets were collected and 
washed in PBS before dispersal by mechanical shaking 
at 37°C for 3 min in 0.05% trypsin, 0.7 mM EDTA. 
The enzymatic reaction was stopped by the addition of 
RPMI 1640 culture medium, and after centrifugation 
at 400 x g for 10 min, the cells were washed in PBS and 
placed in the appropriate medium, depending on the 
experimental protocol.
Pancreatic islet cell viability assay
Viability of islet cells was determined by simultane-
ously staining live and dead cells using a two-color flu-
orescence staining: acridine orange (AO) and propid-
ium iodide (PI). Live cells stained green, while dead 
cells stained red. A working solution was prepared 
(0.6 µL AO from 5mg/mL and 10 µL PI from 1mg/
mL stock solutions) in 1 mL PBS. Dye mix (25 µl) 
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was added to the cell suspension and transferred to 
a microscope slide. Cells were visualized using Leica 
DMLB fluorescence microscope.
5-bromo-2ʹ-deoxyuridine (Brdu) incorporation
The isolated islets were dispersed into single cells with 
trypsin/EDTA as described above. The cells were then 
centrifuged and resuspended in RPMI 1640 without 
phenol red (Cambrex, Belgium), which contained 
10% fetal bovine serum (Thermo Scientific), 2 mM L-
glutamine, 200 U/mL penicillin and 0.2 mg/mL strep-
tomycin. Single cell suspensions were plated on glass 
covers and cultured for 48 h in the presence of 10 µM 
BrdU (Sigma, Madrid, Spain). The cells were fixed for 
2 min with 4% PFA and washed with PBS. The cells 
were then treated with 2 N HCl for 20 min at 37°C 
and washed three times with 0.1 M Na2B4O7 (pH 8.5). 
The cells were permeabilized with 1% Triton X-100 
for 5 min. Non-specific interactions were blocked with 
PBS supplemented with 5% normal goat serum for 1 
h. The cells were probed with mouse anti-BrdU (1:20, 
Dako, M0744) and rabbit anti-insulin (1:200 Abcam, 
ab181547) antibodies overnight at 4 °C. After 5 con-
secutive washing steps, islet cells were incubated with 
secondary antibodies: goat anti-mouse Alexa Fluor 
488 was used at 1:500 and goat anti-Rabbit IgG Alexa 
Fluor 594 (A-11037) was used at 5 mg/mL for 1 h 
at room temperature. Nuclei were stained with 1 µM 
Ethidium Homidimer-1 for 15 min at room tempera-
ture. BrdU- or insulin-positive cells were represented 
as the percentage from a total number of 1000 cells 
(100%) per coverslip.
Calcium imaging
The isolated pancreatic islets were incubated in the 
presence of 5 µM fura-2-acetoxymethyl ester (Fura-
2 AM; Molecular Probes) for at least 1 h at room 
temperature in a modified HBSS buffer (pH 7.35), 
containing 120 mM NaCl, 25 mM NaHCO3, 5 mM 
KCl, 1.1 mM MgCl2 supplemented with 2.5 mM CaCl2 
and increasing concentrations (3, 8 or 11 mM) of D-
glucose. Calcium records in the whole islets of Lang-
erhans were obtained by imaging intracellular calcium 
under an inverted epifluorescence microscope (Zeiss, 
Axiovert 200). Images were acquired every ~3 s with 
an extended Hamamatsu Digital Camera C4742-95 
(Hamamatsu Photonics, Barcelona, Spain), using a 
dual filter wheel (Sutter Instrument CO, CA, USA) 
equipped with 340 and 380 nm, 10 nm bandpass filters 
(Omega optics, Madrid, Spain). Data were acquired 
using ORCA software from Hamamatsu (Hamamatsu 
Photonics, Barcelona, Spain). The results were ex-
pressed as the ratios of 340 nm/380 nm wavelengths. 
The results were plotted and analyzed using commer-
cially available software (Sigmaplot, Jandel Scientific).
Rt-qPCR analysis
Isolated pancreatic islets of Langerhans served as con-
trol, nontreated or incubated in 40 ng/mL of CXCL12α 
for 30 min and 12 h. Total RNA from the control and 
CXCL12α-treated islets was extracted using the RNe-
asy Mini Kit (74106, Qiagen). For cDNA synthesis, 1 
μg of the total RNA was reverse-transcribed using the 
QuantiTect Rev. Transcription Kit (205311, Qiagen) 
and oligo(dT) primers. For RT-qPCR the Maxima 
SYBR Green/ROX qPCR Master Mix (Fermentas) was 
used. mRNA levels were quantitatively determined 
with an ABI Prism 7000 Sequence Detection system 
(Applied Biosystems). The fragments were amplified 
using the following primer sets: upstream 5ʹ-GAT-
TCTTTGAGAGCCATGTC-3ʹ and downstream 
5ʹ-GTCTGTTGTTGCTTTTCAGC-3ʹ for the rat 
Cxcl12 gene; upstream 5ʹ-CTGACTGGTACTTT-
GGGAAA-3ʹ and downstream 5ʹ-GGAACACCAC-
CATCCACAGG-3ʹ for the rat Cxcr4 gene; upstream 
5ʹ-ATGTGCTGCTGTATACCCTC-3ʹ and down-
stream 5ʹ-GTGATGACGACCCACAGATC-3ʹ for 
the rat Cxcr7 gene; upstream 5ʹ-CAAGCTGGAGAA-
GAATGAGG-3ʹ and downstream 5ʹ-TCACCTGTTC-
CTCAAGGGAG-3ʹ for the rat Trpm2 gene; upstream 
5ʹ-AACGGCACCCTCTTACCTTT-3ʹ and down-
stream 5ʹ-TGCTGACATAGGACCTGCTG-3ʹ for 
the rat Lc type of calcium channel gene (CACNA1c); 
upstream 5ʹ-AAGAGGACCTGGCAGATGAA-3ʹ and 
downstream 5ʹ-TTGAGCATTTTCCTCCCAAC-3ʹ 
for the rat Ld type of calcium channel gene (CAC-
NA1d); upstream 5ʹ-AGATTACTGCCCTGGCTC-
CT-3ʹ and downstream 5ʹ-ACATCTGCTGGAAG-
GTGGAC-3ʹ for the rat β-actin gene. The real-time 
PCR program for quantitative RT-PCR was as follows: 
an initial step at 50°C for 2 min, followed by an initial 
denaturation step at 95°C for 10 min and a subsequent 
two-step PCR program at 95°C for 15 s and at 60°C 
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for 60 s for 40 cycles. Negative controls lacking the 
template were used in all RT-qPCR reactions. The 
expression levels of target genes were related to the 
averaged expression level of rat β-actin as the house-
keeping gene.
Measurement of insulin secretion
For insulin secretion, the 48-h-cultured islets were 
washed for 2 h with a modified HBSS buffer (pH 7.35) 
when gassed with 95% O2 and 5% CO2. Groups of 
5 islets were then transferred to 400 µl of a buffer 
solution containing (in mmol/L) 140 NaCl, 4.5 KCl, 
2.5 CaCl2, 1 MgCl2, 20 HEPES and the corresponding 
concentration of glucose (3, 8 or 11 mmol/L), with 
a final pH of 7.4. Subsequently, 100 μL of the buffer 
solution with the corresponding glucose concentra-
tion and 5% BSA was added, followed by incubation at 
room temperature for 3 min and a cool-down period 
of 15 min on ice. Then the medium was collected, and 
the insulin content was measured in duplicate samples 
via radioimmunoassay (RIA) using a Coat-a-Count 
kit (Siemens, Los Angeles, CA, USA). The protein 
concentration was measured using the Bradford dye 
method [20].
statistical analysis
Data are expressed as the mean±SEM. Pairwise com-
parisons were made using the Student’s t-test, unless 
stated otherwise. A probability level of p<0.05 was 
considered statistically significant.
Results
CXCl12α exerts proliferative and prosurvival 
effects on pancreatic islet cells
To examine the beneficial effect of CXCL12α on pan-
creatic β-cells, the islets of Langerhans were isolated 
from male OF1 mice and pretreated with 40 ng/mL 
of CXCL12α prior to exposure to 7.5 µM hydrogen 
peroxide, which served to induce oxidative stress (Fig. 
1). The proliferative potential of the pretreatment with 
CXCL12α was validated by BrdU incorporation for 48 
h, followed by double-staining with anti-BrdU and 
anti-insulin antibodies (Fig. 1A). Statistically signifi-
cant increases in the number of double-stained BrdU 
and insulin positive cells after the pretreatment of is-
lets with CXCL12α as compared to control cells were 
observed (inset in Fig. 1A). Overnight incubation of 
the islets decreased cell viability to about 70%, where-
as the treatment with hydrogen peroxide decreased 
cell viability further, which was observed as a 15% 
higher number of dead cells (Fig. 1B). However, when 
the islets were incubated overnight with 40 ng/mL of 
CXCL12α and exposed to oxidative stress, their vi-
ability remained at the control level. This result shows 
that CXCL12α provided for an increased proliferative 
potential and improved the ability of β-cells to with-
stand oxidative stress.
Fig. 1. CXCL12α increases pancreatic beta-cell proliferation in 
basal conditions and protects islets from hydrogen peroxide-in-
duced cell death. A – Proliferation assay of control and islet cells 
incubated with CXCL12α (40 ng/mL) for 48 h. Cells were double-
stained with anti-insulin (INS), displayed in red, and anti-BrdU 
(BrdU) displayed in green. B – Viability assay of control islet cells 
or pretreated with recombinant CXCL12α (40 ng/mL) before and 
after treatment with a 7.5-µM concentration of hydrogen peroxide. 
C – Alteration of [Ca2+]i of islet cells consecutively treated with 
7.5 µM of hydrogen peroxide. Isolated islets were preloaded with 
Fura-2AM and intracellular calcium-dependent fluorescence was 
measured. The physiological response was initiated with 11 mM 
of D-glucose (11G) and challenged with successive islet treatment 
with 7.5 μM of hydrogen peroxide (3G-3 mM D-glucose). The 
insets represent one islet captured during the calcium imaging (a 
– phase contrast microscopy) stained with EtBr homodimer after 
the measurement (b). One representative result from three inde-
pendent experiments is shown. *p value from Student’s t-test <0.05.
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CXCl12α preserves islet cell functionality by 
normalizing their Ca2+ response under oxidative 
stress
To assess the functionality of β-cells under oxidative 
stress, we analyzed the rise in [Ca2+]i that primes cells 
for insulin release. [Ca2+]i served as a dynamic param-
eter of islet functionality in response to stimulatory 
glucose concentration. In our experimental setup, 
we first examined whether a 7.5-µM concentration 
of hydrogen peroxide influences [Ca2+]i. Isolated is-
lets were preloaded with Fura-2 AM and subjected 
to calcium imaging (Fig. 1C). Exposure to hydrogen 
peroxide completely abolished the influx of Ca2+ so 
that the glucose-induced [Ca2+]i response to 11 mM 
of D-glucose was clearly decreased. As shown on Fig. 
1C, the initial Ca2+ spike observed after the first hy-
drogen peroxide injection and D-glucose stimulation 
was absent; however, some oscillations could still be 
detected. The second hydrogen peroxide treatment of 
the same islet and exposure to 11 mM of D-glucose 
did not provoke a rise in [Ca2+]i, indicating unrespon-
siveness of the islet cells to glucose stimulus.
To check whether CXCL12α increases cell viability 
by influencing Ca2+ influx, isolated islets were incubat-
ed overnight with 40 ng/mL of CXCL12α, preloaded 
with Fura-2 AM and subjected to calcium imaging. 
Islet viability was challenged with 25 mM KCl, which 
depolarizes the cell membrane and impedes Ca2+ in-
flux. The control islets exhibited the usual response to 
a high glucose challenge, observed as an increase in 
intracellular Ca2+ concentration (Fig. 2A). In contrast, 
islets treated with 7.5 µM hydrogen for 1 h exhibited 
decreased responsiveness to the high D-glucose treat-
ment (Fig. 2B), displayed as an irregular Ca2+ spike 
followed by an oscillatory pattern. When the same 
experimental setup was applied to islets that were in-
cubated overnight with 40 ng/mL of CXCL12α prior 
to exposure to 7.5 µM hydrogen peroxide for 1 h (Fig. 
2C), the CXCL12α-pretreated islets exhibited a physi-
ological response to high glucose that was comparable 
to the response elicited in control islets. The protec-
tive capacity of CXCL12α was further tested on islets 
that were exposed to a 10-fold higher concentration 
(75 µM) of hydrogen peroxide. This concentration 
of hydrogen peroxide, which induced a high level of 
oxidative stress, initiated widespread cell death, so that 
the islet cells were unable to properly respond to the 
high D-glucose concentration (Fig. 2D). The pretreat-
ment of islet cells with CXCL12α did not preserve cell 
functionality at the level of oxidative stress induced 
by 75 µM hydrogen peroxide (Fig. 2E).
Fig. 2. Treatment of pancreatic islets with CXCL12α preserves 
islet’s functionality by normalizing Ca2+ uptake. Intracellular Ca2+-
dependent fluorescence was measured in control islets (A) and 
islets treated with a 7.5-µM hydrogen peroxide concentration (B, 
D) with and without overnight islet incubation with CXCL12α (40 
ng/mL) (C, E). The islet’s membrane depolarization was induced 
with 25 mM KCl, while the islet’s physiological response was initi-
ated with 11 mM of glucose. One representative result from three 
independent experiments is shown.
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CXCl12α modulates Ca2+ oscillations in islet cells 
in response to high glucose
The deterioration of pancreatic β-cell function over 
time in T2D is the consequence of poor glycemic 
control and the continuous exposure of β-cells to the 
deleterious effects of reactive oxygen species (ROS). 
We examined whether CXCL12α could improve the 
response of pancreatic islet cells in the hyperglycemic 
state. To that end, [Ca2+]i was monitored in isolated 
islets preloaded with Fura-2 AM (Fig. 3). As can be 
seen in Fig. 3A, when islets were treated with 3 mM of 
D-glucose supplemented with 40 ng/mL of CXCL12α, 
their intracellular Ca2+ concentration did not change, 
and islet functionality was preserved, which was 
confirmed by their response to the high, 11-mM D-
glucose concentration. When islets were exposed to 
a moderate to high, 8-mM D-glucose concentration 
(Fig. 3B), the initial Ca2+ spike was followed by con-
tinuous oscillations as a result of the repeated entry 
of Ca2+. A mix of 8 mM D-glucose and 40 ng/mL of 
CXCL12α induced changes in the mode of Ca2+ entry 
and overall [Ca2+]i, manifesting as an oscillatory pat-
tern with longer-lasting oscillations with a lower fre-
quency. Calculation of the overall Ca2+ uptake revealed 
that CXCL12α modulated Ca2+ influx, resulting in in-
creased [Ca2+]i (inset in Fig. 3B). The same result was 
obtained when islet cells were challenged with 11 mM 
of D-glucose (Fig. 3C). In this setup, the islets were 
probed with 11 mM D-glucose, as well as in combina-
tion with two CXCL12α concentrations (20 and 40 ng/
mL). Treatments with both CXCL12α concentrations 
decreased the number of oscillations that also lasted 
longer, which pointed to an overall increase in [Ca2+]i 
(inset in Fig. 3C), with the 40-ng/mL CXCL12α con-
centration showing a more significant effect.
CXCl12α signaling influences the expression of 
voltage-gated Ca2+ channels in pancreatic islets
The voltage-gated calcium (Cav) channels in β-cells are 
molecular switches that play a central role in insulin 
secretion. The observation that CXCL12α is capable of 
modifying Ca2+ oscillations and increasing [Ca2+]i led 
us to assume that the CXCL12α/receptor axis regulates 
the behavior of the Cav channels. To examine this fur-
Fig. 3. Direct stimulatory effect of CXCL12α on intracellular calcium concentration. The 
CXCL12α stimulates a dose-dependent increase in intracellular calcium. Islets were stimulated 
with 3 mM (A), 8 mM (B) or 11 mM of D-glucose (C) supplemented with or without CXCL12α. 
Ca2+ influx and number of oscillations were calculated in the same time interval (5 min). *p value 
from the Student’s t-test <0.05. One representative result from four independent experiments 
is shown.
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ther, isolated islets were incubated either for 30 min 
or overnight with 40 ng/mL of CXCL12α, and their 
mRNA was isolated (Fig. 4). CXCL12 acts via two re-
ceptors, CXCR4 and CXCR7. RT-qPCR experiments 
revealed that the mRNAs encoding for both receptors 
were significantly increased after the 30-min incuba-
tion of islets with CXCL12α (Fig. 4). The overnight 
incubation with CXCL12α induced a 2-fold increase 
in CXCR4 mRNA, while the level of CXCR7 mRNA 
was unchanged. This result revealed that CXCR7 gene 
transcription was considerably lower in islets as com-
pared to CXCR4 gene transcription. Further, RT-qPCR 
experiments revealed that CXCL12α also induced insu-
lin mRNA synthesis in islet cells. The exposure of islets 
to CXCL12α for 30 min induced a 4-fold increase in 
insulin mRNA synthesis, while overnight islet incuba-
tion with CXCL12a did not cause a significant increase 
in insulin gene transcription.
Next, we analyzed the expression of voltage-gated 
L-type Ca2+ channels that belong to the high-threshold 
type of channels and are opened by large depolariza-
tions, that contribute to the β-cell Ca2+ current and 
insulin secretion. After the 30-min incubation with 
CXCL12α, the mRNAs for both Lc and Ld subtypes 
were significantly increased (2.5- and 6-fold, respec-
tively). The overnight incubation with CXCL12α 
induced less pronounced but significant increases 
in Lc and Ld mRNAs (Fig. 4). We also analyzed the 
Ca2+-permeable, nonselective cation channel TRPM2, 
which is gated by intracellular ADP-ribose and has 
a key role in hydrogen peroxide-induced Ca2+ tran-
sients and cell death [21]. In pancreatic islets under 
physiological conditions, TRPM2 mRNA was barely 
detectable. After the 30-min incubation with 40 ng/
mL of CXCL12α, a small, insignificant increase was 
observed (Fig. 4), and after the overnight incubation 
with CXCL12α, a significant decrease in TRPM2 gene 
transcription was measured, pointing to the prosur-
vival effect of CXCL12α in islet cells.
CXCl12α stimulated insulin release in the 
hyperglycemic state
An increase in blood glucose concentrations induces 
a series of cellular events leading to the depolariza-
tion of the β-cell plasma membrane that opens CaV 
channels to mediate Ca2+ influx and stimulate insulin 
secretion. In the next set of experiments we exam-
ined whether the increase in [Ca2+]i, observed after 
the incubation of pancreatic islets with CXCL12α, 
was also linked with insulin secretion. The islets were 
incubated either for 30 min (Fig. 5A) or overnight 
(Fig. 5B) with 40 ng/mL of CXCL12α, followed by 
treatment with 8 mM and 11 mM of D-glucose, and 
their insulin secretion was measured by RIA. Under 
physiological conditions, in the presence of 3 mM of 
D-glucose, CXCL12α did not affect insulin secretion. 
Stimulatory glucose concentrations induced increased 
insulin secretion, further enhanced in the presence 
of CXCL12α (Fig. 5). Incubation with CXCL12α for 
30 min induced significant insulin release after ex-
Fig. 4. CXCL12α influence on gene expression for insulin, CXCR4, 
CXCR7, Lc/Ld and TRPM2 Ca2+ channels. Transcription rate 
(mRNA levels) of Cxcl12α, Cxcr4, Cxcr7, Lc/Ld types of calcium 
channels and Trpm2 in basal conditions and after increasing times 
of incubation with 40 ng/mL of CXCL12α was estimated by RT-
qPCR. Relative mRNA levels are presented as the ratios of each 
gene/β-actin. (*) Mean values were significantly different from 
those of untreated control cells (p<0.05). Results are expressed 
as the means±SEM from three separate experiments performed 
in triplicate.
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posure to 8 mM and 11 mM of D-glucose (compared 
to matching controls, 2.18- and 1.53-fold increases, 
respectively; Fig. 5A). The overnight incubation of 
islets with CXCL12α induced significant but slightly 
lower increases in insulin secretion after exposure to 8 
mM and 11 mM of D-glucose (compared to matching 
controls, 1.59- and 1.35-fold increase, respectively) 
compared to the 30-min incubation with CXCL12α 
(Fig. 5B). These findings underlined that the presence 
of CXCL12α in the cell medium increases insulin re-
lease in islets by enhancing Ca2+ uptake.
dIsCussIon
Hyperglycemia contributes to the reduction of insulin 
secretion and to the progression from glucose intoler-
ance to T2D [22], causing pancreatic β-cell dysfunc-
tion and decreasing the β-cell mass [23,24]. Therefore, 
β-cell protection remains the focus of strategies for the 
prevention and treatment of diabetes [25]. In general, 
the diabetogenic environment, including insulin re-
sistance and low-grade systemic islet inflammation 
contribute toward the stunning of pancreatic β-cells, 
i.e. a state of temporary incapacity to properly respond 
to the presence of increased glucose concentration by 
secreting insulin [26]. The aim of the present study 
was to examine whether CXCL12α exhibits a benefi-
cial effect on pancreatic β-cells’ ability to release insu-
lin and whether it improves the response of pancreatic 
islets in the hyperglycemic state.
Antidiabetic action of CXCl12α: normalizing 
Ca2+ uptake in order to preserve the functionality 
of islets
In overweight and obese individuals, pancreatic 
β-cells are exposed to metabolic changes and the 
consequences thereof, including oxidative stress re-
sulting from increased ROS and RNS production. 
As a ligand of two receptors, CXCR4 and CXCR7, 
CXCL12 signaling is crucial for β-cell differentiation 
and pancreatic islet genesis [27]. Recent animal stud-
ies revealed the essential role of CXCL12 in duct cell 
survival, proliferation and migration during pancre-
atic regeneration, through its ability to activate Akt, 
Src and the extracellular signal-regulated protein ki-
nase (ERK1/2) [28]. Our group also showed that the 
role of CXCL12 in diabetes attenuation is based on its 
ability to activate the antinecrotic/prosurvival pathway 
after hydrogen peroxide treatment [17]. In this study, 
we examined oxidative stress as a potential inducer 
of β-cell dysfunction [29]. Both effects, proliferative 
burst and increased survival rate of pancreatic β-cells, 
observed after islet incubation with CXCL12α could 
be accomplished by the direct influence of CXCL12 
on intracellular Ca2+ influx.
It is widely accepted that exogenous ROS induces 
dynamic changes in Ca2+ concentration in a variety 
of cell types [30-35]. This effect could be due to the 
mobilization of intracellular Ca2+ stores and influx 
of extracellular Ca2+. An important feature of cross-
regulation between ROS and Ca2+ is that the ROS ef-
fect on Ca2+ signaling can vary from stimulatory to 
repressive, depending on the type of oxidants, their 
concentrations and the duration of exposure. The ef-
Fig. 5. CXCL12α stimulated glucose-induced insulin release. In-
sulin secretion in response to 3, 8 or 11 mM of glucose was meas-
ured in intact islets of Langerhans after 30 min (A) and overnight 
incubation (B) with CXCL12α (40 ng/mL). *p value from Student’s 
t-test <0.05 **p<0.01 value from Student’s t-test.
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fect of ROS on Ca2+ signaling is also tissue-specific 
(reviewed in [36]). We found that CXCL12α preserves 
mouse islet functionality by normalizing their Ca2+ 
response under oxidative stress (hydrogen peroxide 
treatment). In contrast, islet cell treatment with a 
10-times higher concentration of hydrogen peroxide 
(75 µM) induced a constant entry of Ca2+, which in-
dicated cell death as a consequence of exposure to the 
very high concentration of peroxide treatment. This 
finding is in accordance with previous studies showing 
that hydrogen peroxide causes an increase in intracel-
lular Ca2+ levels that leads to cell death in a variety of 
cell types [37-41]. The mechanism whereby hydrogen 
peroxide causes an increase in [Ca2+]i is still under 
debate, with several options proposed, including the 
involvement of voltage-gated Ca2+ channels (Cav) [41], 
nonspecific changes in membrane calcium perme-
ability [42], alteration in Na+-Ca2+ exchange [38], or 
changes in Ca2+ release from intracellular stores [43]. 
Using the insulin-secreting cell line CRI-G1 and very 
high hydrogen peroxide concentrations (1-10 mM), 
Herson et al. [44] described the effects of hydrogen 
peroxide on [Ca2+]i. They clearly demonstrated that 
hydrogen peroxide disrupts calcium homeostasis. In 
contrast, it has also been reported that hydrogen per-
oxide exerts no significant effect on the L-type Ca2+ 
current in pancreatic β-cells [45].
On the other hand, a chronic exposure of pancre-
atic islets to nonphysiological high glucose concentra-
tions caused adverse alterations in β-cell functioning 
in a phenomenon referred to as glucose toxicity, which 
may play a secondary pathogenic role in T2D. Several 
results suggested that one mechanism of glucose toxic-
ity in β-cells may be linked to chronic exposure of cells 
to ROS (or chronic oxidative stress) [46-48]. Both low 
and high concentrations of glucose have been shown 
to increase intracellular peroxide levels within the is-
lets [49], which indicates that glucose metabolism is 
essential for the induction of glucose toxicity. This 
is in agreement with Ihara et al. [50], who reported 
elevated levels of oxidative stress markers (8-hydroxy-
2’-deoxyguanosine and 4-hydroxy-2-nonenal-mod-
ified proteins) in the β-cells of Goto-Kakizaki rats. 
Our experimental setup is suitable for observing β-cell 
behavior in hyperglycemic conditions, since chronic 
hyperglycemia causes a progressive decline in β-cell 
functioning and their ultimately demise [26,51]. 
Electrical activity and stimulated secretion, coupled 
with intracellular Ca2+ dynamics that allow pancre-
atic β-cells to secrete insulin, first reported by Dean 
and Matthews in 1968 [52], are nowadays accepted 
[53-55]. Cells often respond to changes in stimulus 
intensity by varying the frequency of Ca2+ waves. 
To demonstrate the rescue potential of CXCL12α in 
preventing β-cell dysfunction and exhaustion due 
to sustained hyperglycemia, mouse pancreatic islets 
were exposed to stimulatory glucose concentrations, 
both moderate to high (8 M) and high (11 M), for an 
average duration of 45 min [56,57]. In our study, the 
treatment of β-cells with CXCL12α in hyperglycemic 
conditions decreased the number and duration of Ca2+ 
oscillations, with an overall increase in [Ca2+]i. It has 
been already shown that CXCL12 stimulates Ca2+ flux 
and transients in many cell types [58-60]. Similar to 
our finding, CXCL12 dose-dependently increased 
intracellular Ca2+ in adherent IEC-6 cells in the con-
centrations of 20 and 100 ng/mL [61]. Chemokine-
induced Ca2+ mobilization was not solely a function 
of rat intestinal epithelial cells, since CXCL12 stimu-
lated a rapid increase in Ca2+ within 40 s of ligand 
stimulation in the intestinal carcinoma cell line CaCo2 
cells as well [61]. In human LX2 cells, treatment with 
CXCL12 led to a nearly two-fold increase in relative 
Ca2+ influx, whereas in murine JS1 cells CXCL12 did 
not promote Ca2+ movement [62]. The latter authors 
showed that the CXCL12-influenced hepatic stellate 
cell contraction is not Ca2+ dependent. In addition, 
the Ca2+-influenced CXCL12 secretion has also been 
investigated. Schajnovitz et al. [63] reported that Ca2+ 
is transmitted via gap junctions in contacting cell cul-
tures, and that Ca2+ signaling has a role in bone mar-
row stromal cell CXCL12 secretion.
CXCl12α signaling influences the expression 
of voltage-gated Ca2+ channels in pancreatic 
islets and stimulates insulin release in the 
hyperglycemic state
In a high-glucose environment and/or in the presence 
of ROS, voltage-gated Ca2+ (Cav) channels are acti-
vated, allowing extracellular Ca2+ to enter [64-67]. It is 
generally accepted that the subsequent increase in cy-
tosolic Ca2+ triggers insulin release, even though there 
is some evidence for a [Ca2+]i-independent second 
phase of insulin release [68]. Thus, regulation of Cav 
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activity and/or density may result in lower or higher 
insulin secretion [69-77]. Insulin release must be able 
to anticipate glucose increase and prevent persistent 
glucose elevations [26,78]. Insulin secretion analysis in 
rat insulinoma and primary islet cells revealed that N- 
and L-type channels are both involved in immediate 
glucose-induced insulin secretion. However, L-type 
Cav channel was preferentially coupled to secretion 
at a later phase. P/Q-type channels were not found 
to play any role in insulin secretion at any stage [79]. 
In our experimental setup, the exogenously added 
CXCL12α influenced [Ca2+]i and insulin release, pro-
moting less frequent oscillations of [Ca2+]i with longer 
duration, and allowing more Ca2+ to enter the islet. 
One explanation for this increase in [Ca2+]i could be 
linked to the ability of exogenously added CXCL12α 
to enhance gene expression of the Lc (Cav1.2-subunit)/
Ld (Cav1.3-subunit) types of Cav, shown in our ex-
periments. The main subtype of the L-type of chan-
nels in mouse islet β-cells is the Ld subtype [77], al-
though the Lc and Ld subtypes share almost a 70% 
homology [80]. In agreement with previous reports, 
herein we showed that CXCL12α increases the tran-
scription rate of Cav L-type channels, in particular 
Ld-type, which contains the α1D subunit and repre-
sents the Cav1.3α1 channel subtype. We also observed 
an increase in N-type channels due to the increased 
presence of CXCL12. The increased transcriptional 
rate for the N-type of channels was significant but 
7.2-fold less pronounced as compared to the increase 
in the transcriptional rate for the L-type Cav channels 
(data not shown). In contrast, Barg et al. [81] found 
no differences in Ca2+-current density and Cav1.3/
α1D-deficient β-cells, and concluded that Cav1.2 is 
the principal L-type Ca2+ channel subtype in mouse 
β-cells. The functional consequences of the increase in 
Cav channel transcription rate may be relevant in dis-
eases, such as T2D, since β-cells operate with very few 
Cav channels [55,82]. The observed CXCL12α-related 
influence could provide β-cells with a mechanism to 
push Ca2+-coupled regulation of insulin secretion in 
response to elevated glucose.
Since [Ca2+]i dynamics are also responsible for 
β-cell fate [55], we examined whether the Trpm2 Ca2+ 
channel is upregulated due to an excess of CXCL12α. 
Trpm2, a calcium-permeable nonselective cation 
channel expressed in the plasma membrane is criti-
cally involved in ROS-induced processes and is im-
plicated in cell death [83]. In contrast to Cav channels, 
CXCL12α has no influence on the transcription rate 
of Trpm2 after 30 min of incubation, in contrast to 
overnight incubation, which caused a lowering of the 
transcription of the Trpm2 channel gene. The primary 
gating mechanism of Trpm2 involves the binding of 
ADP-ribose polymers (ADPR) [84], but Trpm2 cur-
rents can also be activated by reactive oxygen spe-
cies (ROS) [85] through ROS-induced ADPR release 
from mitochondria [86]. Bearing in mind that the role 
of Trpm2 in pancreatic β-cells involves situations in 
which β-cells are stressed [87,88], the observed down-
regulation of Trpm2 mRNA in our experiments is not 
surprising. As a small chemokine, CXCL12 exerts 
its effect via coupling to its receptors, CXCR4 and 
CXCR7. The 30-min incubation with CXCL12α was 
followed by an increase in the level of Cxcr4 mRNA. 
The increased Ca2+ influx in islet cells was accompa-
nied by increased transcription of the Cxcr7 and Ins. 
Our RT-qPCR results showed significantly increased 
transcription of both receptor genes after islet incuba-
tion with CXCL12α, targeting CXCR4 as the most im-
portant receptor responsible for signaling within the 
islet. This is in accordance with previous reports in-
dicating that CXCL12 is involved in the regulation of 
insulin secretion [89]. β-cell injury induces CXCL12 
expression and the secreted CXCL12 causes dediffer-
entiation of adjacent -cells into pro-α-cells, which are 
further transformed into pancreatic β-cells [18, 90].
β-cell Cav channel activity can be modulated by 
changes in membrane potential and through a vari-
ety of signaling pathways, such as protein phospho-
rylation, Ca2+-dependent inactivation and through 
interaction with G protein (reviewed in [91]). The 
observation that CXCL12α is capable to modify Ca2+ 
oscillations and increase [Ca2+]i as well as influence 
the transcription of Lc and Ld Ca2+ channel genes, led 
us to assume that the CXCL12α/receptor axis regulates 
the behavior of the Cav channels. Princen et al. [92] 
showed that a transient dose-dependent increase in 
intracellular Ca2+ concentration is an essential com-
ponent of the signal transduction cascade activated 
upon CXCL12 binding to its receptor CXCR4. The 
authors showed that in all examined CXCR4+ cell 
lines, CXCL12 elicited a transient [Ca2+]i increase. 
For each cell line, the magnitude of the response was 
related to the level of CXCR4 expression. Published 
data suggest that CXCR4 signaling may not be limited 
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to the G-protein-coupled receptor (GPCR) Gαi, and 
that CXCR4 can couple to other Gα protein subunits 
such as Gαq, Gαo, and Gαs in order to stimulate Ca2+ 
flux [93]. However, it has been proven that Ca2+ flux is 
associated with the GPCR subunit Gαq but not to Gαi 
[94]. Quite the opposite, Hsu et al. [95] proposed that 
the L-type Cav channel in insulin-secreting cells is the 
major mediator of the somatostatin-induced inhibi-
tion of insulin secretion by the activation of G protein-
coupled receptors. In the same line, Renstrom et al. 
[96] reported that stimulation of GPCRs in mouse 
islet β-cells does not influence the voltage activated 
Ca2+ influx. Our assumption of the CXCL12/receptor 
axis being a mediator in the elevated voltage activated 
Ca2+ influx in pancreatic β cells is supported by Roe 
et al. [97], who reported that decreased L-type chan-
nel activity and expression were associated with T2D.
Defects in the metabolic regulation of insulin se-
cretion contribute to the development of T2D. Rescu-
ing stunned β-cells is possibly a key therapeutic target 
for the treatment and prevention of diabetes progres-
sion. It seems reasonable to propose that bringing any 
degree of hyperglycemia under tight control as early 
as possible can switch on stunned β-cells, in spite of 
the fact that glycemic memory and genetic/epigenetic 
programming may differ in every individual. Identi-
fication of the factors that regulate the overall Ca2+ 
intake, activity and expression of Cav channels and 
insulin release may provide a better understanding of 
pancreatic β-cell functioning in normal and diabetic 
states. CXCL12 displayed the potential to regulate 
[Ca2+]i and the transcription of Cav channel genes and 
thus may serve as a potential T2D attenuator.
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